38 results on '"Gallardo ME"'
Search Results
2. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
- Author
-
Berta Laquente, M. E. Gallardo, A. Calsina, S. Arévalo, I. Gonzalez, B. G. de Paredes, I. Alés, A. M. López, Rosa Alvarez, Fernando Lopez-Rios, Juan José Reina, Josefa Plaza, Elena Escalera Martín, Manuel Hidalgo, Ovidio Hernando, M. Salgado, Carmen Guillén-Ponce, J. Blázquez, José Montans, R. Yaya, Teresa Macarulla, Alfredo Carrato, C. Lopez, Alfonso Sanjuanbenito, R. Vera, P. Jiménez, Teresa Bascarán Fernández, A. Muñoz, Javier Gallego, I. Peiró, Luis Iglesias Díez, Alfonso Martínez, R. Pazo, Juan José Martínez, R. Díaz, E. de Madaria, Jorge Adeva, A. Carmona, [Hidalgo,M] Spanish National Cancer Centre, Madrid, Spain. Beth Israel Deaconess Medical Center, Boston, USA. [Álvarez,R] Department of Medical Oncology, Centro Integral Oncológico Clara Campal, Madrid, Spain. [Gallego,J] University Hospital of Elche, Elche, Spain. [Guillén-Ponce,C, Carrato,A] Hospital Universitario Ramón y Cajal, Madrid, Spain. [Laquente,B] Institut Catalá d’Oncologia, Duran y Reynals Hospital, Hospitalet Llobregat, Barcelona, Spain. [Macarulla,T] Vall d’Hebrón University Hospital, Barcelona, Spain. [Muñoz,A] University Hospital Gregorio Marañón, Madrid, Spain. [Salgado,M] University Hospital of Ourense, Ourense, Spain. [Vera,R] Complejo Hospitalario de Navarra, Pamplona, Spain. [Adeva,J] University Hospital 12 de Octubre, Madrid, Spain. [Alés,I] Hospital Carlos Haya, Málaga, Spain. [Arévalo,S] University Hospital Donostia, San Sebastián, Spain. [Blázquez,J] Department of Radiology, University Hospital Ramón y Cajal, Madrid, Spain.MD Anderson Hospital, Madrid, Spain. [Calsina,A] Department of Palliative Care, Hospital Germans Trias I Pujol, Institut Catalá d’Oncologia, Badalona, Spain. [Carmona,A] Department of Medical Oncology and Hematology, University Hospital Morales Messeguer, Murcia, Spain. [de Madaria,E] Department of Gastroenterology, Hospital General Universitario de Alicante, Alicante, Spain. [Díaz,R] Department of Medical Oncology, Hospital Universitari I Politécnic La Fe, Valencia, Spain. [Díez,L] Department of Surgery, Hospital Clínico San Carlos, Madrid, Spain. [Fernández,T] Department of Medical Oncology, Hospital Son Llàtzer, Palma de Mallorca, Spain. [de Paredes,BG] Hospital Clínico San Carlos, Madrid, Spain. [Gallardo,ME] Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain. [González,I] Complejo Hospitalario de Granada, Granada, Spain. [Hernando,O] Department of Radiotherapy, University Hospital HM Sanchinarro, Madrid, Spain. University Hospital HM Puerta del Sur, Madrid, Spain. [Jiménez,P] Department of Medical Oncology, Hospital Universitario Central de Asturias, Asturias, Spain. [López,A] Hospital Universitario de Burgos, Burgos, Spain. [López,C] Hospital Universitario Marqués de Valdecilla, Santander, Spain. [López-Ríos,F, and Plaza,JC] Department of Pathology, University Hospital HM Sanchinarro, Madrid, Spain. [Martín,E] Department of Surgery, Hospital Universitario de la Princesa, Madrid, Spain. [Martínez,J] Department of Medical Oncology, University Hospital Virgen de las Nieves, Granada, Spain. [Martínez,A] Hospital del Mar, Barcelona, Spain. [Montans,J] Department of Pathology, Centro Anatomopatológico, Madrid, Spain. [Pazo,R] Department of Medical Oncology, University Hospital Miguel Servet, Saragossa, Spain. [Peiró,I] Department of Endocrinology, Instituto Catalán de Oncología, Hospital Duran I Reynals, Hospitalet de Llobregat, Barcelona, Spain. [Reina,JJ] Department of Medical Oncology, University Hospital Virgen de la Macarena, Seville, Spain. [Sanjuanbenito,A] Department of Surgery, University Hospital Ramón y Cajal, Madrid, Spain. [Yaya,R] Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
- Subjects
Diseases::Digestive System Diseases::Pancreatic Diseases::Pancreatic Neoplasms::Carcinoma, Pancreatic Ductal [Medical Subject Headings] ,Cancer Research ,medicine.medical_treatment ,humanos ,Disease ,Guideline ,oncología médica ,estudios de seguimiento ,Medical Oncology ,Treatment and control groups ,Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings] ,0302 clinical medicine ,guías de práctica clínica como asunto ,Consensus guidelines, Diagnosis, Pancreatic cancer, Treatment ,neoplasias pancreáticas ,Diagnosis ,Publication Type::Publication Formats::Guideline [Medical Subject Headings] ,Tratamiento ,Medical diagnosis ,àncrees -- Càncer -- Tractament ,Guías ,General Medicine ,Humanos ,Diagnosis treatment ,Oncology ,030220 oncology & carcinogenesis ,Practice Guidelines as Topic ,030211 gastroenterology & hepatology ,Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genetic Code::Reading Frames [Medical Subject Headings] ,Early stage disease ,Carcinoma ductal pancreático ,Carcinoma, Pancreatic Ductal ,medicine.medical_specialty ,Tratamento ,guía ,Special Article ,03 medical and health sciences ,Pancreatic cancer ,medicine ,Humans ,Sistemas de lectura ,Consensus guidelines ,Chemotherapy ,business.industry ,General surgery ,Carcinoma ,medicine.disease ,Surgery ,Clinical trial ,Diseases::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [Medical Subject Headings] ,Cáncer de páncreas ,Treatment ,Pancreatic Neoplasms ,Spain ,business ,Follow-Up Studies - Abstract
The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended., The support for medical writing was supported by Fundacion ECO.
- Published
- 2016
3. Creation of an Isogenic Human iPSC-Based RGC Model of Dominant Optic Atrophy Harboring the Pathogenic Variant c.1861C>T (p.Gln621Ter) in the OPA1 Gene.
- Author
-
García-López M, Jiménez-Vicente L, González-Jabardo R, Dorado H, Gómez-Manjón I, Martín MÁ, Ayuso C, Arenas J, and Gallardo ME
- Subjects
- Humans, CRISPR-Cas Systems, Gene Editing methods, Mutation, Apoptosis genetics, Reactive Oxygen Species metabolism, Mitochondria metabolism, Mitochondria genetics, Optic Atrophy, Autosomal Dominant genetics, Optic Atrophy, Autosomal Dominant pathology, Optic Atrophy, Autosomal Dominant metabolism, Induced Pluripotent Stem Cells metabolism, GTP Phosphohydrolases genetics, GTP Phosphohydrolases metabolism, Retinal Ganglion Cells metabolism, Retinal Ganglion Cells pathology
- Abstract
Autosomal dominant optic atrophy (ADOA) is a rare progressive disease mainly caused by mutations in OPA1 , a nuclear gene encoding for a mitochondrial protein that plays an essential role in mitochondrial dynamics, cell survival, oxidative phosphorylation, and mtDNA maintenance. ADOA is characterized by the degeneration of retinal ganglion cells (RGCs). This causes visual loss, which can lead to legal blindness in many cases. Nowadays, there is no effective treatment for ADOA. In this article, we have established an isogenic human RGC model for ADOA using iPSC technology and the genome editing tool CRISPR/Cas9 from a previously generated iPSC line of an ADOA plus patient harboring the pathogenic variant NM_015560.3: c.1861C>T (p.Gln621Ter) in heterozygosis in OPA1 . To this end, a protocol based on supplementing the iPSC culture media with several small molecules and defined factors trying to mimic embryonic development has been employed. Subsequently, the created model was validated, confirming the presence of a defect of intergenomic communication, impaired mitochondrial respiration, and an increase in apoptosis and ROS generation. Finally, we propose the analysis of OPA1 expression by qPCR as an easy read-out method to carry out future drug screening studies using the created RGC model. In summary, this model provides a useful platform for further investigation of the underlying pathophysiological mechanisms of ADOA plus and for testing compounds with potential pharmacological action.
- Published
- 2024
- Full Text
- View/download PDF
4. Hereditary Optic Neuropathies: A Systematic Review on the Interplay between Biomaterials and Induced Pluripotent Stem Cells.
- Author
-
Ladero M, Reche-Sainz JA, and Gallardo ME
- Abstract
Hereditary optic neuropathies (HONs) such as dominant optic atrophy (DOA) and Leber Hereditary Optic Neuropathy (LHON) are mitochondrial diseases characterized by a degenerative loss of retinal ganglion cells (RGCs) and are a cause of blindness worldwide. To date, there are only limited disease-modifying treatments for these disorders. The discovery of induced pluripotent stem cell (iPSC) technology has opened several promising opportunities in the field of HON research and the search for therapeutic approaches. This systematic review is focused on the two most frequent HONs (LHON and DOA) and on the recent studies related to the application of human iPSC technology in combination with biomaterials technology for their potential use in the development of RGC replacement therapies with the final aim of the improvement or even the restoration of the vision of HON patients. To this purpose, the combination of natural and synthetic biomaterials modified with peptides, neurotrophic factors, and other low- to medium-molecular weight compounds, mimicking the ocular extracellular matrices, with human iPSC or iPSC-derived cell retinal progenitors holds enormous potential to be exploited in the near future for the generation of transplantable RGC populations.
- Published
- 2024
- Full Text
- View/download PDF
5. Creation of an iPSC-Based Skeletal Muscle Model of McArdle Disease Harbouring the Mutation c.2392T>C (p.Trp798Arg) in the PYGM Gene.
- Author
-
Cerrada V, García-Consuegra I, Arenas J, and Gallardo ME
- Abstract
McArdle disease is a rare autosomal recessive condition caused by mutations in the PYGM gene. This gene encodes the skeletal muscle isoform of glycogen phosphorylase or myophosphorylase. Patients with McArdle disease have an inability to obtain energy from their muscle glycogen stores, which manifests as a marked exercise intolerance. Nowadays, there is no cure for this disorder and recommendations are intended to prevent and mitigate symptoms. There is great heterogeneity among the pathogenic variants found in the PYGM gene, and there is no obvious correlation between genotypes and phenotypes. Here, we present the generation of the first human iPSC-based skeletal muscle model harbouring the second most frequent mutation in PYGM in the Spanish population: NM_005609.4: c.2392T>C (p.Trp798Arg). To this end, iPSCs derived from a McArdle patient and a healthy control were both successfully differentiated into skeletal muscle cells using a small molecule-based protocol. The created McArdle skeletal muscle model was validated by confirming distinctive biochemical aspects of the disease such as the absence of myophosphorylase, the most typical biochemical feature of these patients. This model will be very valuable for use in future high-throughput pharmacological screenings.
- Published
- 2023
- Full Text
- View/download PDF
6. Generation of the First Human In Vitro Model for McArdle Disease Based on iPSC Technology.
- Author
-
Ortuño-Costela MDC, Cerrada V, Moreno-Izquierdo A, García-Consuegra I, Laberthonnière C, Delourme M, Garesse R, Arenas J, Fuster García C, García García G, Millán JM, Magdinier F, and Gallardo ME
- Subjects
- Humans, Glycogen metabolism, Technology, Glycogen Storage Disease Type V genetics, Induced Pluripotent Stem Cells metabolism, Glycogen Phosphorylase, Muscle Form
- Abstract
McArdle disease is a rare autosomal recessive disorder caused by mutations in the PYGM gene. This gene encodes for the skeletal muscle isoform of glycogen phosphorylase (myophosphorylase), the first enzyme in glycogenolysis. Patients with this disorder are unable to obtain energy from their glycogen stored in skeletal muscle, prompting an exercise intolerance. Currently, there is no treatment for this disease, and the lack of suitable in vitro human models has prevented the search for therapies against it. In this article, we have established the first human iPSC-based model for McArdle disease. For the generation of this model, induced pluripotent stem cells (iPSCs) from a patient with McArdle disease (harbouring the homozygous mutation c.148C>T; p.R50* in the PYGM gene) were differentiated into myogenic cells able to contract spontaneously in the presence of motor neurons and generate calcium transients, a proof of their maturity and functionality. Additionally, an isogenic skeletal muscle model of McArdle disease was created. As a proof-of-concept, we have tested in this model the rescue of PYGM expression by two different read-through compounds (PTC124 and RTC13). The developed model will be very useful as a platform for testing drugs or compounds with potential pharmacological activity.
- Published
- 2022
- Full Text
- View/download PDF
7. Development and Validation of the Mexican Public Open Spaces Tool (MexPOS).
- Author
-
Medina C, Hernández A, Hermosillo-Gallardo ME, Gómez Gámez CI, Resendiz E, Morales M, Nieto C, Moreno M, and Barquera S
- Subjects
- Cities, Humans, Mexico, Environment Design, Exercise
- Abstract
Public open spaces (POS) are "publicly owned spaces such as parks, green areas, squares, marketplaces, streets and highways which are of public access". Some attributes could increase or decrease participants' attendance. Thus, reliable and valid audit tools are needed in order to measure these attributes. This study aimed to develop and validate a tool to assess POS features within the Mexico City context. The Mexican Public Open Spaces Tool (MexPOS) was developed based on (1) two validated POS audit tools, (2) several visits to the POS, (3) pilot testing, and (4) multiple work sessions with a group of specialists. The original tool included 181 items divided into nine sections. Trained personnel visited and evaluated 944 POS in Mexico City. An exploratory factor analysis was performed to examine the construct validity of the items and the relationship between the subscales. The final model resulted in seven factors: (1) Food and Wellness Environment (α = 0.15), (2) Maintenance (α = 0.81), (3) Amenities (α = 0.72), (4) Legibility (α = 0.59), (5) Security (α = 0.48), (6) Perceived Environment (α = 0.65), and (7) Urban Environment (α = 0.58). Our study highlights the relevance of using a validated tool to measure POS characteristics related to participants' attendance to help assess infrastructure improvements and identify priority areas for changing socio-urban environments for physical activity.
- Published
- 2022
- Full Text
- View/download PDF
8. Hereditary Optic Neuropathies: Induced Pluripotent Stem Cell-Based 2D/3D Approaches.
- Author
-
García-López M, Arenas J, and Gallardo ME
- Subjects
- Humans, Cell Differentiation, DNA, Mitochondrial genetics, DNA, Mitochondrial metabolism, Genetic Diseases, Inborn genetics, Genetic Diseases, Inborn metabolism, Genetic Diseases, Inborn pathology, Induced Pluripotent Stem Cells metabolism, Induced Pluripotent Stem Cells pathology, Mitochondria genetics, Mitochondria metabolism, Optic Nerve Diseases genetics, Optic Nerve Diseases metabolism, Optic Nerve Diseases pathology
- Abstract
Inherited optic neuropathies share visual impairment due to the degeneration of retinal ganglion cells (RGCs) as the hallmark of the disease. This group of genetic disorders are caused by mutations in nuclear genes or in the mitochondrial DNA (mtDNA). An impaired mitochondrial function is the underlying mechanism of these diseases. Currently, optic neuropathies lack an effective treatment, and the implementation of induced pluripotent stem cell (iPSC) technology would entail a huge step forward. The generation of iPSC-derived RGCs would allow faithfully modeling these disorders, and these RGCs would represent an appealing platform for drug screening as well, paving the way for a proper therapy. Here, we review the ongoing two-dimensional (2D) and three-dimensional (3D) approaches based on iPSCs and their applications, taking into account the more innovative technologies, which include tissue engineering or microfluidics.
- Published
- 2021
- Full Text
- View/download PDF
9. Generation of the iPSC line IISHDOi007-A from peripheral blood mononuclear cells from a patient with McArdle disease harbouring the mutation c.2392 T > C; p.Trp798Arg.
- Author
-
Cerrada V, García-López M, Alvarez-Galeano S, Moreno-Izquierdo A, Lucia A, Rabasa Pérez M, Arenas J, and Gallardo ME
- Subjects
- Humans, Kruppel-Like Factor 4, Leukocytes, Mononuclear, Mutation genetics, Cell Line, Glycogen Storage Disease Type V, Induced Pluripotent Stem Cells
- Abstract
Peripheral blood mononuclear cells (PBMCs) from a McArdle patient carrying a homozygous mutation in the PYGM gene: c.2392 T > C; p.Trp798Arg were used for the generation of the human iPSC line, IISHDOi007-A. For the delivery of the reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc, a non-integrative methodology that implies the use of Sendai virus has been applied., (Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
10. Perception of Safety and Its Association With Physical Activity in Adolescents in Mexico.
- Author
-
Hermosillo-Gallardo ME, Sebire SJ, and Jago R
- Subjects
- Adolescent, Cross-Sectional Studies, Female, Humans, Leisure Activities psychology, Male, Mexico, Residence Characteristics, Schools, Sports statistics & numerical data, Students statistics & numerical data, Surveys and Questionnaires, Transportation statistics & numerical data, Crime statistics & numerical data, Exercise physiology, Perception, Safety
- Abstract
Introduction: Low levels of physical activity are associated with several noncommunicable diseases. In Mexico, 39.5% of adolescents do not meet WHO physical activity guidelines. Previous literature suggests an association between perception of safety and physical activity. This paper examines the association between perceived crime and pedestrian safety and physical activity in Mexican adolescents., Methods: This cross-sectional study used data from 4,079 adolescents aged 15-18 years in Mexico. Physical activity was measured with the Youth Physical Activity Questionnaire and was grouped into the following 5 domains: (1) moderate-to-vigorous physical activity, (2) sports activity, (3) leisure time activity, (4) physical education class, and (5) active commuting to school. Perception of safety was measured as pedestrian safety and crime safety, using the Neighborhood Environment Walkability Scale-Youth. Confirmatory factor analysis was performed to examine the construct validity of this scale on the Mexican population. Data were collected in 2017 and analyzed in 2018. Associations between physical activity and perception of safety were examined using linear regression models., Results: Low perception of pedestrian safety was associated with lower moderate-to-vigorous physical activity per week (coefficient= -0.12, 95% CI= -0.19, -0.05) and lower sports activity per week (coefficient= -0.13, 95% CI= -0.23, -0.03) in female adolescents. There was no association between perception of safety and physical activity among male adolescents., Conclusions: Pedestrian safety was negatively associated with moderate-to-vigorous physical activity and sports participation in female youth. Environments with better lighting, crosswalks, and walking/cycle trails could increase physical activity in female youth., (Copyright © 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
11. Mitochondrial Dysfunction and Calcium Dysregulation in Leigh Syndrome Induced Pluripotent Stem Cell Derived Neurons.
- Author
-
Galera-Monge T, Zurita-Díaz F, Canals I, Hansen MG, Rufián-Vázquez L, Ehinger JK, Elmér E, Martin MA, Garesse R, Ahlenius H, and Gallardo ME
- Subjects
- Blotting, Western, Cell Proliferation physiology, Cells, Cultured, Electrophysiology, Fluorescent Antibody Technique, Humans, Lactic Acid metabolism, Leigh Disease pathology, Mitochondria metabolism, Neural Stem Cells cytology, Neural Stem Cells metabolism, Neurons cytology, Neurons metabolism, Oxygen Consumption genetics, Calcium metabolism, Induced Pluripotent Stem Cells cytology, Induced Pluripotent Stem Cells metabolism, Leigh Disease metabolism, Oxygen Consumption physiology
- Abstract
Leigh syndrome (LS) is the most frequent infantile mitochondrial disorder (MD) and is characterized by neurodegeneration and astrogliosis in the basal ganglia or the brain stem. At present, there is no cure or treatment for this disease, partly due to scarcity of LS models. Current models generally fail to recapitulate important traits of the disease. Therefore, there is an urgent need to develop new human in vitro models. Establishment of induced pluripotent stem cells (iPSCs) followed by differentiation into neurons is a powerful tool to obtain an in vitro model for LS. Here, we describe the generation and characterization of iPSCs, neural stem cells (NSCs) and iPSC-derived neurons harboring the mtDNA mutation m.13513G>A in heteroplasmy. We have performed mitochondrial characterization, analysis of electrophysiological properties and calcium imaging of LS neurons. Here, we show a clearly compromised oxidative phosphorylation (OXPHOS) function in LS patient neurons. This is also the first report of electrophysiological studies performed on iPSC-derived neurons harboring an mtDNA mutation, which revealed that, in spite of having identical electrical properties, diseased neurons manifested mitochondrial dysfunction together with a diminished calcium buffering capacity. This could lead to an overload of cytoplasmic calcium concentration and the consequent cell death observed in patients. Importantly, our results highlight the importance of calcium homeostasis in LS pathology.
- Published
- 2020
- Full Text
- View/download PDF
12. Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations.
- Author
-
Cruz-Bermúdez A, Vallejo CG, Vicente-Blanco RJ, Gallardo ME, Fernández-Moreno MÁ, Quintanilla M, and Garesse R
- Abstract
[This corrects the article DOI: 10.18632/oncotarget.3698.]., (Copyright: © 2020 Cruz-Bermúdez et al.)
- Published
- 2020
- Full Text
- View/download PDF
13. The Challenge of Bringing iPSCs to the Patient.
- Author
-
Ortuño-Costela MDC, Cerrada V, García-López M, and Gallardo ME
- Subjects
- Humans, Precision Medicine methods, Cell Differentiation, Induced Pluripotent Stem Cells transplantation, Precision Medicine trends
- Abstract
The implementation of induced pluripotent stem cells (iPSCs) in biomedical research more than a decade ago, resulted in a huge leap forward in the highly promising area of personalized medicine. Nowadays, we are even closer to the patient than ever. To date, there are multiple examples of iPSCs applications in clinical trials and drug screening. However, there are still many obstacles to overcome. In this review, we will focus our attention on the advantages of implementing induced pluripotent stem cells technology into the clinics but also commenting on all the current drawbacks that could hinder this promising path towards the patient.
- Published
- 2019
- Full Text
- View/download PDF
14. The mutation m.13513G>A impairs cardiac function, favoring a neuroectoderm commitment, in a mutant-load dependent way.
- Author
-
Galera-Monge T, Zurita-Díaz F, Garesse R, and Gallardo ME
- Subjects
- Cell Differentiation genetics, Electron Transport Complex I genetics, Embryonic Development genetics, Epithelial-Mesenchymal Transition genetics, Heart Diseases pathology, Humans, Induced Pluripotent Stem Cells metabolism, Leigh Disease pathology, Mitochondria genetics, Mitochondria pathology, Mitochondrial Diseases metabolism, Mitochondrial Diseases pathology, Mitochondrial Proteins genetics, Mutation, Myocytes, Cardiac metabolism, Myocytes, Cardiac pathology, Neural Plate growth & development, Neural Plate pathology, Phenotype, DNA, Mitochondrial genetics, Electron Transport genetics, Heart Diseases genetics, Leigh Disease genetics, Mitochondrial Diseases genetics
- Abstract
Mitochondrial disorders (MDs) arise as a result of a respiratory chain dysfunction. While some MDs can affect a single organ, many involve several organs, the brain being the most affected, followed by heart and/or muscle. Many of these diseases are associated with heteroplasmic mutations in the mitochondrial DNA (mtDNA). The proportion of mutated mtDNA must exceed a critical threshold to produce disease. Therefore, understanding how embryonic development determines the heteroplasmy level in each tissue could explain the organ susceptibility and the clinical heterogeneity observed in these patients. In this report, the dynamics of heteroplasmy and the influence in cardiac commitment of the mutational load of the m.13513G>A mutation has been analyzed. This mutation has been reported as a frequent cause of Leigh syndrome (LS) and is commonly associated with cardiac problems. In this report, induced pluripotent stem cell (iPSc) technology has been used to delve into the molecular mechanisms underlying cardiac disease in LS. When mutation m.13513G>A is above a threshold, iPSc-derived cardiomyocytes (iPSc-CMs) could not be obtained due to an inefficient epithelial-mesenchymal transition. Surprisingly, these cells are redirected toward neuroectodermal lineages that would give rise to the brain. However, when mutation is below that threshold, dysfunctional CM are generated in a mutant-load dependent way. We suggest that distribution of the m.13513G>A mutation during cardiac differentiation is not at random. We propose a possible explanation of why neuropathology is a frequent feature of MD, but cardiac involvement is not always present., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
15. Derivation of a human DOA iPSC line, IISHDOi006-A, with a mutation in the ACO2 gene: c.1999G>A; p.Glu667Lys.
- Author
-
Cerrada V, García-López M, Moreno-Izquierdo A, Villaverde C, Zurita O, Martin-Merida MI, Arenas J, Ayuso C, and Gallardo ME
- Subjects
- Aconitate Hydratase metabolism, Cell Differentiation, Cell Line cytology, Cellular Reprogramming, Fibroblasts cytology, Fibroblasts metabolism, Humans, Induced Pluripotent Stem Cells cytology, Kruppel-Like Factor 4, Male, Mutation, Missense, Optic Atrophy, Autosomal Dominant metabolism, Optic Atrophy, Autosomal Dominant physiopathology, Point Mutation, Aconitate Hydratase genetics, Cell Line metabolism, Induced Pluripotent Stem Cells metabolism, Optic Atrophy, Autosomal Dominant genetics
- Abstract
Human iPSC line, IISHDOi006-A, was obtained from fibroblasts of a patient with Dominant Optic Atrophy (DOA) carrying a heterozygous mutation in the gene ACO2: c.1999G>A; p.Glu667Lys. Reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc were delivered using a non-integrative methodology that involves the use of Sendai virus., (Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
16. iPSCs: A powerful tool for skeletal muscle tissue engineering.
- Author
-
Del Carmen Ortuño-Costela M, García-López M, Cerrada V, and Gallardo ME
- Subjects
- Animals, Cell Culture Techniques methods, Humans, Induced Pluripotent Stem Cells cytology, Kruppel-Like Factor 4, Kruppel-Like Transcription Factors genetics, Kruppel-Like Transcription Factors metabolism, Muscle, Skeletal metabolism, Muscle, Skeletal physiology, Octamer Transcription Factor-3 genetics, Octamer Transcription Factor-3 metabolism, Precision Medicine methods, Proto-Oncogene Proteins c-myc genetics, Proto-Oncogene Proteins c-myc metabolism, SOXB1 Transcription Factors genetics, SOXB1 Transcription Factors metabolism, Tissue Scaffolds, Cellular Reprogramming Techniques methods, Induced Pluripotent Stem Cells metabolism, Muscle, Skeletal cytology, Regeneration physiology, Tissue Engineering methods
- Abstract
Both volumetric muscle loss (VML) and muscle degenerative diseases lead to an important decrease in skeletal muscle mass, condition that nowadays lacks an optimal treatment. This issue has driven towards an increasing interest in new strategies in tissue engineering, an emerging field that can offer very promising approaches. In addition, the discovery of induced pluripotent stem cells (iPSCs) has completely revolutionized the actual view of personalized medicine, and their utilization in skeletal muscle tissue engineering could, undoubtedly, add myriad benefits. In this review, we want to provide a general vision of the basic aspects to consider when engineering skeletal muscle tissue using iPSCs. Specifically, we will focus on the three main pillars of tissue engineering: the scaffold designing, the selection of the ideal cell source and the addition of factors that can enhance the resemblance with the native tissue., (© 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.)
- Published
- 2019
- Full Text
- View/download PDF
17. Derivation of an aged mouse induced pluripotent stem cell line, IISHDOi005-A.
- Author
-
Ortuño-Costela MDC, Cerrada V, García-López M, Arenas J, Martínez J, Lucia A, Garesse R, and Gallardo ME
- Subjects
- Aging pathology, Animals, Cell Differentiation, Cellular Reprogramming Techniques, Fibroblasts, Karyotype, Kruppel-Like Factor 4, Mice, Inbred C57BL, Sendai virus, Cell Line, Induced Pluripotent Stem Cells
- Abstract
A mouse iPSC line, IISHDOi005-A, generated from fibroblasts obtained from a mouse C57BL/6J with an age of 1 year and a half, has been obtained. For this purpose, reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc were delivered using Sendai virus., (Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
18. Association between urbanicity and physical activity in Mexican adolescents: The use of a composite urbanicity measure.
- Author
-
Hermosillo-Gallardo ME, Jago R, and Sebire SJ
- Subjects
- Adolescent, Cross-Sectional Studies, Female, Humans, Male, Mexico, Exercise, Urban Population, Urban Renewal
- Abstract
Purpose: In Mexico, 39.5% of adolescents do not meet the World Health Organisation's physical activity guidelines. Urbanicity is a potential correlate of physical activity. The aim of this study was to examine the associations between different aspects of urbanicity and adolescents' physical activity., Methods: Participants were 4,079 Mexican adolescents aged 15-18 from Mexico City and Oaxaca, Mexico. Data was collected between February and June 2016. Multiple imputation of missing data was implemented after confirming values were missing at random. Multivariable regression models examined associations between five domains of self-reported physical activity: 1) moderate-to-vigorous physical activity, 2) sports activities, 3) leisure time activities, 4) Physical Education class at school, 5) active commuting to school; and a composite measure of urbanicity and its seven sub-scores: 1) demographic, 2) economic activity, 3) built environment, 4) communication, 5) education, 6) diversity and 7) health services. Multivariable regression models were adjusted for parents' education and participants' age., Results: Urbanicity was positively associated with activity spent in Physical Education class. The association between urbanicity and sport activities depended on state context. Communication-based urbanicity was negatively associated with leisure physical activity and active commuting. Population density was positively associated with active commuting., Conclusion: Urbanicity is associated with adolescents' physical activity in Mexico. Findings were largely consistent between Mexico City and Oaxaca and highlight the value of examining urbanicity as a multidimensional construct., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
19. Establishment of a human iPSC line, IISHDOi004-A, from a patient with Usher syndrome associated with the mutation c.2276G>T; p.Cys759Phe in the USH2A gene.
- Author
-
Zurita-Díaz F, Ortuño-Costela MDC, Moreno-Izquierdo A, Galbis L, Millán JM, Ayuso C, Garesse R, and Gallardo ME
- Subjects
- Cell Line, Humans, Kruppel-Like Factor 4, Mutation, Extracellular Matrix Proteins genetics, Induced Pluripotent Stem Cells metabolism, Usher Syndromes genetics
- Abstract
A human iPSC line, IISHDOi004-A, from fibroblasts obtained from a patient with Usher syndrome, harboring a homozygous mutation in the USH2A gene (c.2276G>T; p.Cys759Phe) has been generated. Reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc were delivered using Sendai virus., (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
20. Generation and characterization of two human iPSC lines from patients with methylmalonic acidemia cblB type.
- Author
-
Richard E, Brasil S, Briso-Montiano A, Alonso-Barroso E, Gallardo ME, Merinero B, Ugarte M, Desviat LR, and Pérez B
- Subjects
- Alkyl and Aryl Transferases genetics, Amino Acid Substitution, Female, Humans, Kruppel-Like Factor 4, Male, Amino Acid Metabolism, Inborn Errors genetics, Amino Acid Metabolism, Inborn Errors metabolism, Amino Acid Metabolism, Inborn Errors pathology, Cellular Reprogramming Techniques, Induced Pluripotent Stem Cells metabolism, Induced Pluripotent Stem Cells pathology, Mutation, Missense, Transcription Factors biosynthesis, Transcription Factors genetics
- Abstract
Two human induced pluripotent stem cell (iPSC) lines were generated from fibroblasts of two siblings with methylmalonic acidemia cblB type carrying mutations in the MMAB gene: c.287T➔C (p.Ile96Thr) and a splicing loss-of-function variant c.584G➔A affecting the last nucleotide of exon 7 in MMAB (p.Ser174Cysfs*23). Reprogramming factors OCT3/4, SOX2, KLF4 and c-MYC were delivered using a non-integrative method based on the Sendai virus. Once established, iPSCs have shown full pluripotency, differentiation capacity and genetic stability., (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
21. Generation of a human iPSC line, IISHDOi002-A, with a 46, XY/47, XYY mosaicism and belonging to an African mitochondrial haplogroup.
- Author
-
Ortuño-Costela MDC, Moreno-Izquierdo A, Garesse R, and Gallardo ME
- Subjects
- Base Sequence, Cell Differentiation, Cell Line, Humans, Infant, Newborn, Karyotyping, Kruppel-Like Factor 4, Male, Mycoplasma isolation & purification, Black People genetics, Cell Culture Techniques methods, Chromosomes, Human genetics, Haplotypes genetics, Mitochondria genetics, Mosaicism
- Abstract
We have generated a human iPSC line, IISHDOi002-A, from commercial primary normal human dermal fibroblasts belonging to an African mitochondrial haplogroup (L3), and with a 46, XY/47, XYY mosaicism. For this purpose, reprogramming factors Oct3/4, Sox2, Klf4 and cMyc were delivered using a non-integrative methodology that involves the use of Sendai virus., (Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
22. Establishment of a human DOA 'plus' iPSC line, IISHDOi003-A, with the mutation in the OPA1 gene: c.1635C>A; p.Ser545Arg.
- Author
-
Zurita-Díaz F, Galera-Monge T, Moreno-Izquierdo A, Corton M, Ayuso C, Garesse R, and Gallardo ME
- Subjects
- Cell Line, GTP Phosphohydrolases pharmacology, Humans, Kruppel-Like Factor 4, Male, Mutation, Optic Atrophy, Autosomal Dominant metabolism, Optic Atrophy, Autosomal Dominant pathology, GTP Phosphohydrolases genetics, Optic Atrophy, Autosomal Dominant genetics
- Abstract
We have generated a human iPSC line IISHDOi003-A from fibroblasts of a patient with a dominant optic atrophy 'plus' phenotype, harbouring a heterozygous mutation, c.1635C>A; p.Ser545Arg, in the OPA1 gene. Reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc were delivered using Sendai virus., (Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
23. Adjuvant treatment for pancreatic ductal carcinoma.
- Author
-
Macarulla T, Fernández T, Gallardo ME, Hernando O, López AM, and Hidalgo M
- Subjects
- Chemoradiotherapy, Adjuvant, Humans, Prognosis, Carcinoma, Pancreatic Ductal therapy, Neoadjuvant Therapy, Pancreatic Neoplasms therapy
- Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a tumor with a very poor prognosis. Most of the patients are diagnosed in advanced stages of the disease, and 5-year survival rates in these patients remains <10%. Surgery still remains the only radical treatment option, although only 15-20% of patients are candidates for surgical resection at the time of the diagnosis. Patients who undergo radical surgery still have a limited survival rate, being the average of 23 months. Three clinical trials have shown that adjuvant chemotherapy therapy after surgery may improve survival: CONKO-1, ESPAC-3, and ESPAC-4. Adjuvant therapy is recommended in patients with R0/R1, T1-4/N1-0 tumors and with ECOG 0-1. In patients with ECOG-2, the decision needs to be individualized. Treatment schemes that have demonstrated efficacy include gemcitabine alone, 5-fluorouracil, or the combination of gemcitabine and capecitabine for six months. Prior to adjuvant treatment, the following test are recommended: Complete blood tests, including CA19.9 biomarker; imaging studies to rule out early disease relapse (preferable thorax-abdomen-pelvic CT). Studies that have evaluated the efficacy of radiation therapy in the adjuvant setting have presented conflicting results. Its use should be considered in patients with R1 or R2 tumors or in those with lymph nodes involved.
- Published
- 2017
- Full Text
- View/download PDF
24. Establishment of a human iPSC line (IISHDOi001-A) from a patient with McArdle disease.
- Author
-
Ortuño-Costela MDC, Rodríguez-Mancera N, García-López M, Zurita-Díaz F, Moreno-Izquierdo A, Lucía A, Martín MÁ, Garesse R, and Gallardo ME
- Subjects
- Cell Line, Female, Glycogen Storage Disease Type V genetics, Humans, Induced Pluripotent Stem Cells metabolism, Kruppel-Like Factor 4, Mutation genetics, Reproducibility of Results, Cell Culture Techniques methods, Glycogen Storage Disease Type V pathology, Induced Pluripotent Stem Cells pathology
- Abstract
Human iPSC line IISHDOi001-A was generated from fibroblasts of a patient with McArdle disease harbouring the mutation, c.148C>T; p.Arg50Ter, in the PYGM gene. Reprogramming factors Oct3/4, Sox2, Klf4, and c-Myc were delivered using Sendai virus., (Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
25. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
- Author
-
Hidalgo M, Álvarez R, Gallego J, Guillén-Ponce C, Laquente B, Macarulla T, Muñoz A, Salgado M, Vera R, Adeva J, Alés I, Arévalo S, Blázquez J, Calsina A, Carmona A, de Madaria E, Díaz R, Díez L, Fernández T, de Paredes BG, Gallardo ME, González I, Hernando O, Jiménez P, López A, López C, López-Ríos F, Martín E, Martínez J, Martínez A, Montans J, Pazo R, Plaza JC, Peiró I, Reina JJ, Sanjuanbenito A, Yaya R, and Carrato A
- Subjects
- Follow-Up Studies, Humans, Practice Guidelines as Topic, Spain, Carcinoma, Pancreatic Ductal diagnosis, Carcinoma, Pancreatic Ductal therapy, Pancreatic Neoplasms diagnosis, Pancreatic Neoplasms therapy
- Abstract
The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended.
- Published
- 2017
- Full Text
- View/download PDF
26. The Associations Between Urbanicity and Physical Activity and Sitting Time in Mexico.
- Author
-
Hermosillo-Gallardo ME, Jago R, and Sebire SJ
- Subjects
- Adult, Aged, Educational Status, Female, Humans, Linear Models, Male, Mexico, Middle Aged, Nutrition Surveys, Social Class, Young Adult, Exercise, Posture, Sedentary Behavior, Urban Population statistics & numerical data
- Abstract
Background: Approximately 17.4% of people in Mexico self-report physical activity levels below the World Health Organization's guidelines and an average sedentary time of 16 hours per day.
1 Low physical activity has been associated with noncommunicable disease risk factors and previous research suggests that urbanicity might be an important determinant of physical activity. The aim of this study was to measure urbanicity in Mexico and assess if it is associated with physical activity and sitting time., Methods: A sample of 2880 men and 4211 women aged 20 to 69 was taken from the 2012 Mexico National Health and Nutrition Survey and multivariable linear regression models were used to examine the association between physical activity, sitting time and urbanicity; adjusting for sex, education level, socioeconomic status and Body Mass Index. The urbanicity score and the 7 urbanicity subscores were estimated from the CENSUS 2010., Results: The subscores of demographic, economic activity, diversity and communication were negatively associated with physical activity. Sitting time was positively associated with the overall urbanicity, and the demographic and health subscores., Conclusions: There was evidence of associations between urbanicity and physical activity in Mexico.- Published
- 2017
- Full Text
- View/download PDF
27. iPSCs, a Future Tool for Therapeutic Intervention in Mitochondrial Disorders: Pros and Cons.
- Author
-
Galera T, Zurita-Díaz F, Garesse R, and Gallardo ME
- Subjects
- DNA Copy Number Variations genetics, Humans, Mitochondrial Diseases genetics, Mutation genetics, Polymorphism, Single Nucleotide genetics, Induced Pluripotent Stem Cells transplantation, Mitochondrial Diseases therapy
- Abstract
Mitochondrial disorders, although individually are rare, taken together constitute a big group of diseases that share a defect in the oxidative phosphorylation system. Up to now, the development of therapies for these diseases is very slow and ineffective due in part to the lack of appropriate disease models. Therefore, there is an urgent need for the discovery of new therapeutic interventions. Regarding this, the generation of induced pluripotent stem cells (iPSCs) has opened new expectations in the regenerative medicine field. However, special cares and considerations must be taken into account previous to a replacement therapy. J. Cell. Physiol. 231: 2317-2318, 2016. © 2016 Wiley Periodicals, Inc., (© 2016 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
28. Generating Rho-0 Cells Using Mesenchymal Stem Cell Lines.
- Author
-
Fernández-Moreno M, Hermida-Gómez T, Gallardo ME, Dalmao-Fernández A, Rego-Pérez I, Garesse R, and Blanco FJ
- Subjects
- Apoptosis, Cell Differentiation, Cell Line, DNA isolation & purification, DNA metabolism, DNA, Mitochondrial analysis, DNA, Mitochondrial isolation & purification, DNA, Mitochondrial metabolism, Flow Cytometry, Humans, Membrane Potential, Mitochondrial, Mesenchymal Stem Cells cytology, Mitochondria metabolism, Phenotype, Reactive Oxygen Species metabolism, Real-Time Polymerase Chain Reaction, Mesenchymal Stem Cells metabolism
- Abstract
Introduction: The generation of Rho-0 cells requires the use of an immortalization process, or tumor cell selection, followed by culture in the presence of ethidium bromide (EtBr), incurring the drawbacks its use entails. The purpose of this work was to generate Rho-0 cells using human mesenchymal stem cells (hMSCs) with reagents having the ability to remove mitochondrial DNA (mtDNA) more safely than by using EtBr., Methodology: Two immortalized hMSC lines (3a6 and KP) were used; 143B.TK-Rho-0 cells were used as reference control. For generation of Rho-0 hMSCs, cells were cultured in medium supplemented with each tested reagent. Total DNA was isolated and mtDNA content was measured by real-time polymerase chain reaction (PCR). Phenotypic characterization and gene expression assays were performed to determine whether 3a6 Rho-0 hMSCs maintain the same stem properties as untreated 3a6 hMSCs. To evaluate whether 3a6 Rho-0 hMSCs had a phenotype similar to that of 143B.TK-Rho-0 cells, in terms of reactive oxygen species (ROS) production, apoptotic levels and mitochondrial membrane potential (Δψm) were measured by flow cytometry and mitochondrial respiration was evaluated using a SeaHorse XFp Extracellular Flux Analyzer. The differentiation capacity of 3a6 and 3a6 Rho-0 hMSCs was evaluated using real-time PCR, comparing the relative expression of genes involved in osteogenesis, adipogenesis and chondrogenesis., Results: The results showed the capacity of the 3a6 cell line to deplete its mtDNA and to survive in culture with uridine. Of all tested drugs, Stavudine (dt4) was the most effective in producing 3a6-Rho cells. The data indicate that hMSC Rho-0 cells continue to express the characteristic MSC cell surface receptor pattern. Phenotypic characterization showed that 3a6 Rho-0 cells resembled 143B.TK-Rho-0 cells, indicating that hMSC Rho-0 cells are Rho-0 cells. While the adipogenic capability was higher in 3a6 Rho-0 cells than in 3a6 cells, the osteogenic and chondrogenic capacities were lower., Conclusion: Among the drugs and conditions tested, the use of d4t was the best option for producing Rho-0 cells from hMSCs. Rho-0 cells are useful for studying the role of mitochondria in hMSC differentiation., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2016
- Full Text
- View/download PDF
29. Reprogramming for Cardiac Regeneration-Strategies for Innovation.
- Author
-
Sanchis-Gomar F, Galera T, Lucia A, and Gallardo ME
- Subjects
- Humans, Induced Pluripotent Stem Cells cytology, Myocytes, Cardiac physiology, Cell Differentiation physiology, Cell Transdifferentiation, Myocardial Infarction therapy, Myocardium cytology, Regeneration physiology
- Abstract
It is well-known that the human myocardium has a low capacity for self-regeneration. This fact is especially important after acute myocardial infarction with subsequent heart failure and adverse tissue remodeling. New potential strategies have recently emerged for treating heart diseases, such as the possibility of generating large quantities of cardiomyocytes through genetic iPSC reprogramming, transdifferentiation for in vitro disease modeling, in vivo therapies or telomerase gene reactivation. Approaches based on these techniques may represent the new horizon in cardiology with an appropriate 180-degree turn perspective. J. Cell. Physiol. 231: 1849-1851, 2016. © 2016 Wiley Periodicals, Inc., (© 2016 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
30. iPSCs-based anti-aging therapies: Recent discoveries and future challenges.
- Author
-
Pareja-Galeano H, Sanchis-Gomar F, Pérez LM, Emanuele E, Lucia A, Gálvez BG, and Gallardo ME
- Subjects
- Cellular Senescence physiology, Humans, Aging physiology, Cellular Reprogramming, Cellular Reprogramming Techniques methods, Cellular Reprogramming Techniques trends, Induced Pluripotent Stem Cells physiology, Sarcopenia pathology, Sarcopenia physiopathology, Sarcopenia therapy
- Abstract
The main biological hallmarks of the aging process include stem cell exhaustion and cellular senescence. Consequently, research efforts to treat age-related diseases as well as anti-aging therapies in general have recently focused on potential 'reprogramming' regenerative therapies. These new approaches are based on induced pluripotent stem cells (iPSCs), including potential in vivo reprogramming for tissue repair. Another possibility is targeting pathways of cellular senescence, e.g., through modulation of p16INK4a signaling and especially inhibition of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Here, we reviewed and discussed these recent developments together with their possible usefulness for future treatments against sarcopenia, a major age-related condition., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
31. Generation of a human iPSC line from a patient with Leigh syndrome caused by a mutation in the MT-ATP6 gene.
- Author
-
Galera-Monge T, Zurita-Díaz F, González-Páramos C, Moreno-Izquierdo A, Fraga MF, Fernández AF, Garesse R, and Gallardo ME
- Subjects
- Cell Line, Cellular Reprogramming, Humans, Cell Culture Techniques methods, Induced Pluripotent Stem Cells cytology, Induced Pluripotent Stem Cells metabolism, Leigh Disease genetics, Mitochondrial Proton-Translocating ATPases genetics, Mutation genetics
- Published
- 2016
- Full Text
- View/download PDF
32. Generation of a human iPSC line from a patient with an optic atrophy 'plus' phenotype due to a mutation in the OPA1 gene.
- Author
-
Galera-Monge T, Zurita-Díaz F, Moreno-Izquierdo A, Fraga MF, Fernández AF, Ayuso C, Garesse R, and Gallardo ME
- Subjects
- Base Sequence, Cell Differentiation, Cells, Cultured, Cellular Reprogramming, DNA Mutational Analysis, Humans, Induced Pluripotent Stem Cells metabolism, Karyotype, Kruppel-Like Factor 4, Male, Microscopy, Fluorescence, Mutation, Optic Atrophy genetics, Optic Atrophy metabolism, Optic Atrophy pathology, Phenotype, Transcription Factors genetics, Transcription Factors metabolism, Fibroblasts cytology, GTP Phosphohydrolases genetics, Induced Pluripotent Stem Cells cytology
- Abstract
Human iPSC line Oex2054SV.4 was generated from fibroblasts of a patient with an optic atrophy 'plus' phenotype associated with a heterozygous mutation in the OPA1 gene. Reprogramming factors OCT3/4, SOX2, CMYC and KLF4 were delivered using a non-integrative methodology that involves the use of Sendai virus., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
33. IPSCs, a Promising Tool to Restore Muscle Atrophy.
- Author
-
Pareja-Galeano H, Sanchis-Gomar F, Emanuele E, Gallardo ME, and Lucia A
- Subjects
- Aged, Aging pathology, Animals, Cell Differentiation, Humans, Induced Pluripotent Stem Cells cytology, Mice, Muscular Atrophy pathology, Regenerative Medicine, Sarcopenia pathology, Sarcopenia therapy, Induced Pluripotent Stem Cells transplantation, Muscular Atrophy therapy
- Abstract
Induced pluripotent stem cells (iPSCs) are a promising tool for regenerative medicine in chronic conditions associated with muscle atrophy since iPSCs are easier to obtain, pose less ethical limitations and can better capture human genetic diversity compared with human embryonic stem cells. We highlight the potentiality of iPSCs for treating muscle-affecting conditions for which no effective cure is yet available, notably aging sarcopenia and inherited neurometabolic conditions. J. Cell. Physiol. 231: 259-260, 2016. © 2015 Wiley Periodicals, Inc., (© 2015 Wiley Periodicals, Inc.)
- Published
- 2016
- Full Text
- View/download PDF
34. Generation of a human control iPSC line with a European mitochondrial haplogroup U background.
- Author
-
Galera T, Zurita F, González-Páramos C, Moreno-Izquierdo A, Fraga MF, Fernández AF, Garesse R, and Gallardo ME
- Subjects
- Cell Differentiation, Cell Line, DNA Fingerprinting, Europe, Humans, Karyotyping, Kruppel-Like Factor 4, Cell Culture Techniques methods, Haplotypes genetics, Induced Pluripotent Stem Cells cytology, Mitochondria genetics
- Abstract
Human iPSC line N44SV.5 was generated from primary normal human dermal fibroblasts belonging to the European mitochondrial haplogroup U. For this purpose, reprogramming factors Oct3/4, Sox2, Klf4, and cMyc were delivered using a non-integrative methodology that involves the use of Sendai virus.
- Published
- 2016
- Full Text
- View/download PDF
35. Generation of a human iPSC line from a patient with a defect of intergenomic communication.
- Author
-
Zurita F, Galera T, González-Páramos C, Moreno-Izquierdo A, Schneiderat P, Fraga MF, Fernández AF, Garesse R, and Gallardo ME
- Subjects
- Base Sequence, Cell Differentiation, Cell Line, Cellular Reprogramming, DNA Mutational Analysis, DNA Polymerase gamma, Female, Humans, Induced Pluripotent Stem Cells metabolism, Karyotype, Kruppel-Like Factor 4, Microscopy, Fluorescence, Plasmids metabolism, Polymorphism, Single Nucleotide, Transcription Factors genetics, Transcription Factors metabolism, Transfection, DNA-Directed DNA Polymerase genetics, Induced Pluripotent Stem Cells cytology
- Abstract
Human iPSC line PG64SV.2 was generated from fibroblasts of a patient with a defect of intergenomic communication. This patient harbored a homozygous mutation (c.2243G>C; p.Trp748Ser) in the gene encoding the catalytic subunit of the mitochondrial DNA polymerase gamma gene (POLG). Reprogramming factors Oct3/4, Sox2, Klf4, and cMyc were delivered using a non integrative methodology that involves the use of Sendai virus., (Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
36. Generation of a human iPSC line from a patient with a mitochondrial encephalopathy due to mutations in the GFM1 gene.
- Author
-
Zurita-Díaz F, Galera-Monge T, Moreno-Izquierdo A, Fraga MF, Ayuso C, Fernández AF, Garesse R, and Gallardo ME
- Subjects
- Base Sequence, Cell Differentiation, Cell Line, Cellular Reprogramming, DNA Mutational Analysis, Female, Humans, Induced Pluripotent Stem Cells metabolism, Karyotype, Kruppel-Like Factor 4, Microscopy, Fluorescence, Mitochondrial Encephalomyopathies metabolism, Plasmids metabolism, Polymorphism, Single Nucleotide, Sendai virus genetics, Transcription Factors genetics, Transcription Factors metabolism, Transfection, Induced Pluripotent Stem Cells cytology, Mitochondrial Encephalomyopathies pathology, Mitochondrial Proteins genetics, Peptide Elongation Factor G genetics
- Abstract
Human iPSC line GFM1SV.25 was generated from fibroblasts of a child with a severe mitochondrial encephalopathy associated with mutations in the GFM1 gene, encoding the mitochondrial translation elongation factor G1. Reprogramming factors OCT3/4, SOX2, CMYC and KLF4 were delivered using a non integrative methodology that involves the use of Sendai virus., (Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
37. Enhanced tumorigenicity by mitochondrial DNA mild mutations.
- Author
-
Cruz-Bermúdez A, Vallejo CG, Vicente-Blanco RJ, Gallardo ME, Fernández-Moreno MÁ, Quintanilla M, and Garesse R
- Subjects
- Animals, Cell Line, Tumor, DNA, Mitochondrial metabolism, Female, Humans, Mice, Mice, Inbred BALB C, Mice, Nude, Mitochondria genetics, Mitochondria metabolism, Oxygen Consumption, Reactive Oxygen Species metabolism, Carcinogenesis genetics, DNA, Mitochondrial genetics, Mutation
- Abstract
To understand how mitochondria are involved in malignant transformation we have generated a collection of transmitochondrial cybrid cell lines on the same nuclear background (143B) but with mutant mitochondrial DNA (mtDNA) variants with different degrees of pathogenicity. These include the severe mutation in the tRNALys gene, m.8363G>A, and the three milder yet prevalent Leber's hereditary optic neuropathy (LHON) mutations in the MT-ND1 (m.3460G>A), MT-ND4 (m.11778G>A) and MT-ND6 (m.14484T>C) mitochondrial genes. We found that 143B ρ0 cells devoid of mtDNA and cybrids harboring wild type mtDNA or that causing severe mitochondrial dysfunction do not produce tumors when injected in nude mice. By contrast cybrids containing mild mutant mtDNAs exhibit different tumorigenic capacities, depending on OXPHOS dysfunction.The differences in tumorigenicity correlate with an enhanced resistance to apoptosis and high levels of NOX expression. However, the final capacity of the different cybrid cell lines to generate tumors is most likely a consequence of a complex array of pro-oncogenic and anti-oncogenic factors associated with mitochondrial dysfunction.Our results demonstrate the essential role of mtDNA in tumorigenesis and explain the numerous and varied mtDNA mutations found in human tumors, most of which give rise to mild mitochondrial dysfunction.
- Published
- 2015
- Full Text
- View/download PDF
38. Co-occurrence of four nucleotide changes associated with an adult mitochondrial ataxia phenotype.
- Author
-
Zabalza R, Nurminen A, Kaguni LS, Garesse R, Gallardo ME, and Bornstein B
- Subjects
- Aged, Alleles, Amino Acid Sequence, Amino Acid Substitution, Base Sequence, Cerebellar Ataxia physiopathology, DNA Polymerase gamma, Female, Genotype, Humans, Male, Middle Aged, Mitochondria pathology, Models, Molecular, Molecular Sequence Data, Pedigree, Cerebellar Ataxia genetics, DNA, Mitochondrial genetics, DNA-Directed DNA Polymerase genetics, Mitochondria genetics, Mutation, Phenotype
- Abstract
Background: Mitochondrial DNA maintenance disorders are an important cause of hereditary ataxia syndrome, and the majority are associated with mutations in the gene encoding the catalytic subunit of the mitochondrial DNA polymerase (DNA polymerase gamma), POLG. Mutations resulting in the amino acid substitutions A467T and W748S are the most common genetic causes of inherited cerebellar ataxia in Europe., Methods: We report here a POLG mutational screening in a family with a mitochondrial ataxia phenotype. To evaluate the likely pathogenicity of each of the identified changes, a 3D structural analysis of the PolG protein was carried out, using the Alpers mutation clustering tool reported previously., Results: Three novel nucleotide changes and the p.Q1236H polymorphism have been identified in the affected members of the pedigree. Computational analysis suggests that the p.K601E mutation is likely the major contributing factor to the pathogenic phenotype., Conclusions: Computational analysis of the PolG protein suggests that the p.K601E mutation is likely the most significant contributing factor to a pathogenic phenotype. However, the co-occurrence of multiple POLG alleles may be necessary in the development an adult-onset mitochondrial ataxia phenotype.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.